A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-19
- Target Recruit Count
- 30
- Registration Number
- NCT06375642
- Locations
- 🇨🇳
Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin, China
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
- Conditions
- Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma
- Interventions
- Drug: Ivonescimab（AK112，a PD-1/VEGF bispecific antibody）
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-19
- Target Recruit Count
- 30
- Registration Number
- NCT06375486
- Locations
- 🇨🇳
Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin, China
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
- Conditions
- Advanced Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2024-04-17
- Last Posted Date
- 2024-04-17
- Target Recruit Count
- 35
- Registration Number
- NCT06370065
- Locations
- 🇨🇳
Tianjin Cancer Hospital Airport Hospital, Tianjin, Tianjin, China
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial
- Conditions
- Non-small Cell Lung CancerEGFR Activating MutationCell Cycle DeregulationEGFR-TKI Resistant Mutation
- Interventions
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2024-04-16
- Target Recruit Count
- 32
- Registration Number
- NCT06363734
- Locations
- 🇨🇳
Department of Thoracic Medical Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
To Evaluate the Efficacy and Safety of Anrotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-06-21
- Target Recruit Count
- 64
- Registration Number
- NCT06352008
- Locations
- 🇨🇳
Tianiin Medical University Cancer Institute & Hospital, Tianjin, China
A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients
- Conditions
- Predictive Cancer ModelGastric CancerLymph Node Metastasis
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2024-04-01
- Target Recruit Count
- 120
- Registration Number
- NCT06339307
- Locations
- 🇨🇳
Cancer Hospital of Tianjin Medical University, Tianjin, Tianjin, China
Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
- Conditions
- Advanced/Metastatic Colorectal Cancer
- Interventions
- Drug: LTC004+regorafenib
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2024-03-21
- Target Recruit Count
- 20
- Registration Number
- NCT06322563
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Compare the Prognostic Differences Between SBRT and Surgery for NSCLC Patients With Interlobular Fissure Invasion.
- Conditions
- NSCLCRadiotherapySurgery
- Interventions
- Other: Different treatments
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-19
- Target Recruit Count
- 150
- Registration Number
- NCT06317324
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin, China
Rituximab Combined With Prior Therapy in Advanced Hepatocellular Carcinoma: Efficacy & Safety Study
- Conditions
- Advanced Hepatocellular Carcinoma
- Interventions
- Drug: Rituximab+PD-1 or PD-L1 inhibitors+targeted therapy
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-11-20
- Target Recruit Count
- 20
- Registration Number
- NCT06301399
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
Single-center, Prospective Study on the Identification and Delineation of Brain and Lung Tumors and At-Risk Organs, and Functional Testing of Surrounding Tissues Based on Dual-Energy CT
- Conditions
- Image Quality and Contouring Accuracy of the Tumor in Radiotherapy
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-03-08
- Target Recruit Count
- 50
- Registration Number
- NCT06301100
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi, Tianjin, Tianjin, China